BIG
RCKT icon

Brooklyn Investment Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Brooklyn Investment Group’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.3K Sell
11,825
-7,374
-38% -$29.3K ﹤0.01% 1822
2025
Q4 		$66.8K Sell
19,199
-73,895
-79% -$253K ﹤0.01% 1485
2025
Q3 		$236K Sell
93,094
-21,598
-19% -$68K 0.03% 523
2025
Q2 		$281K Buy
+114,692
New +$581K 0.04% 465
2025
Q1 		– Sell
-374
Closed -$4.7K – 2865
2024
Q4 		$4.7K Buy
+374
New +$5.63K ﹤0.01% 1235

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Brooklyn Investment Group's RCKT Position: Q1 2026 in Review

Brooklyn Investment Group reduced its Rocket Pharmaceuticals (RCKT) stake by 38% in Q1 2026, selling an estimated $29.3K and leaving 11,825 shares worth $42.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1822.

Brooklyn Investment Group first reported a position in RCKT in Q4 2024 and has held it in 5 quarters since. The position peaked at $281K in Q2 2025. 199 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Brooklyn Investment Group held 11,825 shares of Rocket Pharmaceuticals worth $42.3K as of Q1 2026.
  • Brooklyn Investment Group sold 7,374 Rocket Pharmaceuticals shares in Q1 2026, an estimated $29.3K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Brooklyn Investment Group's portfolio in Q1 2026, its #1822 holding.
  • Brooklyn Investment Group first reported a position in Rocket Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • Brooklyn Investment Group's Rocket Pharmaceuticals position peaked at $281K in Q2 2025.
  • 199 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.